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Abstract
Background: Nkx2.7 is the tinman-related gene, as well as orthologs of Nkx2.5 and Nkx-2.3. Nkx2.7 and Nkx2.5 express in
zebrafish heart fields of lateral plate mesoderm. The temporal and spatial expression patterns of Nkx2.7 are similar to those
of Nkx2.5, but their functions during cardiogenesis remain unclear.
Methodology/Principal Findings: Here, Nkx2.7 is demonstrated to compensate for Nkx2.5 loss of function and play a
predominant role in the lateral development of the heart, including normal cardiac looping and chamber formation.
Knocking down Nkx2.5 showed that heart development was normal from 24 to 72 hpf. However, when knocking down
either Nkx2.7 or Nkx2.5 together with Nkx2.7, it appeared that the heart failed to undergo looping and showed defective
chambers, although embryos developed normally before the early heart tube stage. Decreased ventricular myocardium
proliferation and defective myocardial differentiation appeared to result from late-stage up-regulation of bmp4, versican,
tbx5 and tbx20, which were all expressed normally in hearts at an early stage. We also found that tbx5 and tbx20 were
modulated by Nkx2.7 through the heart maturation stage because an inducible overexpression of Nkx2.7 in the heart caused
down-regulation of tbx5 and tbx20. Although heart defects were induced by overexpression of an injection of 150-pg Nkx2.5
or 5-pg Nkx2.7 mRNA, either Nkx2.5 or Nkx2.7 mRNA rescued the defects induced by Nkx2.7-morpholino(MO) and Nkx2.5-
MO with Nkx2.7-MO.
Conclusions and Significance: Therefore, we conclude that redundant activities of Nkx2.5 and Nkx2.7 are required for cardiac
morphogenesis, but that Nkx2.7 plays a more critical function, specifically indicated by the gain-of-function and loss-of-
function experiments where Nkx2.7 is observed to regulate the expressions of tbx5 and tbx20 through the maturation stage.
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Introduction
The heart is the first organ to form and function in the vertebrate
embryos. The functional heart is formed after 72 hours post-
fertilization (hpf). During heart developmental processes, cell fate
determination, specification, differentiation and migration are all
involved. In view of this complexity, investigators have used model
systems, including Drosophila, Xenopus, zebrafish, chicken, and
mouse, in an attempt to understand the molecular regulatory
network of cardiogenesis [1–4]. These efforts have produced two
key findings important to the hypothesis of this paper: 1) that the
members of the homeobox gene family are important for heart
development [5] and 2) that the NK-class of homeodomain proteins
plays key roles in the establishment of myogenic lineages [6–11].
Among the homeobox genes, the vertebrate homologs of tinman
have been cloned in many species and are highly conserved in the
homeodomain structures and expression patterns. For example,
Drosophila tinman is involved in the specification of the heart primordial
cells. More specifically, in tinman null mutants, the heart-like dorsal
vessel is absent, indicating that tinman is a critical factor in Drosophila
heart-like formation [6]. The mouse tinman homolog is Nkx2.5,a n d
Nkx2.5-knockout mice exhibit the formation of a primitive heart tube,
which expresses most cardiac markers with the exception of mlc2v.
The mlc2v marker, however, displays a thinning ventricular
myocardium and, therefore, cannot undergo heart looping [7].
Unlike Drosophila tinman,m o u s eNkx2.5 is required for murine normal
heart morphogenesis, but it is not essential for the cell fate
determination of heart precursors. This suggests that there may be
an Nkx homolog that compensates for the loss of function of Nkx2.5 in
mouse embryos. The most likely homolog of mouse Nkx2.5 is mouse
Nkx2.6 which shares identical expression patterns at pharyngeal
endoderm and at heart with Nkx2.5 [12]. Targeted disruption of
Nkx2.6 does not cause any abnormality, either in the pharynx or in
the heart [13]. In Nkx2.5
2/2Nkx2.6
2/2 double knockout mice, the
development of pharynx is totally abolished. Therefore, Tanaka et al.
(2001) demonstrated that Nkx2.5 c a nc o m p e n s a t ef o rt h ef u n c t i o no f
Nkx2.6 in the pharyngeal endoderm [14].
Many tinman (Nkx2.3, 2.5, 2.6, 2.7, 2.8) homologs of chicken,
Xenopus and zebrafish have been isolated [10,15–21]. The example
cited above, mouse Nkx2.5/ Nkx2.6, suggests a redundant activity
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expression partially overlaps with cNkx2.5 and cNkx2.3. This is seen
in the onset of cNkx2.8, which appears at heart primordia and
retains its expression until primary heart tube formation. After
heart tube looping, however, cNkx2.8 is no longer expressed, and
cNkx2.3 initiates expression at this stage and continues to express
until adulthood [22]. Overexpression of cNkx2.8 can transactivate
a minimal promoter containing the cis-acting element for Nkx2.5
binding. In addition, cNkx-2.8 and serum response factor can co-
activate a minimal cardiac a-actin promoter like cNkx2.5 [21].
Still, there is no direct evidence to demonstrate that cNkx2.8 can
compensate for cNkx2.5 loss of function in early development of
chick heart.
In Xenopus, both XNkx2.3 and XNkx2.5 are expressed in cardiac
mesoderm and pharyngeal endoderm [23]. Injection of XNkx2.3 or
XNkx2.5 mRNA causes an abnormally enlarged heart [9].
Although the XNkx2.5 and XNkx2.3 dominant-negative en-
grailed-fusion repressor shows a reduced number of heart cells,
co-injection of both EnHD constructs appears to result in an even
more serious decrease of heart cells. This suggests that XNkx2.5
and XNkx2.3 act redundantly during heart formation [24].
In zebrafish, Nkx2.7 is the tinman-related gene, as well as
orthologs of Nkx2.5 and Nkx2.3. The transcription of zebrafish
Nkx2.7 is earlier than that of Nkx2.5 in cardiac mesoderm, and
Nkx2.7 is also expressed at pharyngeal endodermal precursors.
The temporal and spatial expression patterns of Nkx2.7 are similar
to those of Nkx2.5 [19]. While knockdown of Nkx2.5 in zebrafish
embryos displays no obvious defects in heart, overexpression of
Nkx2.5 did show an enlarged heart and even caused dorsoventral
axial defects [10]. Since it is not known which stages of cardiac
development or which pathways are affected by the Nkx family of
homologs, it may be necessary to knock down more than one of
these genes to discover their dual functions. Meanwhile, the
precise role played by tinman homolog genes in vertebrate cardiac
development remains to be clarified, particularly the dual roles
played by Nkx2.5 and Nkx2.7 in the cardiogenesis of zebrafish
embryos. In this study, we clearly demonstrate that, while Nkx2.5
and Nkx2.7 play redundant roles in the differentiation of
cardiomyocytes, Nkx2.7 has a more critical function, specifically
indicated by the gain-of-function and loss-of-function experiments
where Nkx2.7 is observed to regulate the expressions of tbx5 and
tbx20 through the heart tube stage.
Results
Nkx2.5 and Nkx2.7 double knockdown results in serious
zebrafish embryo heart defects
We designed Nkx2.5- and Nkx2.7-MO to study whether Nkx2.5
or Nkx2.7 is required for heart development of zebrafish. Heart-
specific-GFP transgenic line Tg (cmlc2::GFP) was used to monitor
the cardiac morphology in zebrafish embryos. By fluorescence
microscope, we observed that embryos injected with 10, 12, and
14 ng of Nkx2.5-MO developed normally from 24 to 72 hpf,
although we occasionally observed a small percentage of injected
embryos which had a slight degree of pericardial edema. This was
also observed in the wild-type embryos and in the embryos
injected with a high concentration of control MO (Table 1 and
Fig. 1A). In contrast, embryos injected with Nkx2.7-MO at the
same concentrations totally failed to complete heart looping
during 30 to 72 hpf (Table 1 and Fig. 1B). Moreover, double
knockdown of Nkx2.5 and Nkx2.7 (Nkx2.5/2.7-MO) by injection of
8 ng Nkx2.5-MO combined with 8 ng of Nkx2.7-MO into
embryos displayed a shrunken ventricle and an expanded atrium
with an incomplete heart looping. After 72 hpf, many symptoms of
heart defects appeared in both Nkx2.7 and Nkx2.5/2.7 mor-
phants, including regurgitation of blood, arrhythmia, string-like
heart and pericardial edema (data not shown). The rates of
defective heart occurrence in the Nkx2.7 and the Nkx2.5/2.7
morphants were dose-dependent (Table 1). Comparing the cardiac
defects among Nkx2.5 morphants, Nkx2.7 morphants and
Nkx2.5/2.7 morphants, we observed that the Nkx2.5 morphants
did not have any obvious heart defects, while the Nkx2.7
morphants exhibited an unlooping defect with a low percentage
of shrunken ventricles. The Nkx2.5/2.7 morphants displayed not
only the unlooping defect, but also shrunken ventricles (Table 1).
To confirm that the phenotypes of morphants were specifically
induced by the absence of Nkx2.5/2.7 function, we constructed
plasmids of pCS2-Nkx2.5-GFP and pCS2-Nkx2.7-GFP, in which
the binding sequence of MO was fused with the GFP cDNA.
Unlike the GFP was expressed in the embryos (n=173) injected
Table 1. The cardiac phenotypes of embryos injected with Nkx2.5-MO, Nkx2.7- MO and Nkx2.5/2.7-MO.
Morpholino (ng) Survival numbers of Embryos Abnormal Phenotypes
Nkx2.5 Nkx2.7 Looping Defects Shrinking Ventricle pericardial edema
4 4 142/167 (85.0%) 85(59.8%) 75(52.8%) —
6 6 207/255 (81.2%) 166 (80.2%) 151(72.9%) —
8 8 183/233 (78.6%) 177 (97.8%) 162 (88.5%) —
0 10 115/137 (83.9%) 56(48.7%) 12(10.4%) —
0 12 139/177 (78.5%) 87(62.5%) 27(19.4%) —
0 14 183/246 (74.3%) 143(78.1%) 75(40.9%) —
10 0 24/188 (87.2%) 0 0 21/164(12.8%)
12 0 74/84(88.1%) 0 0 15/76 (19.7%)
14 0 82/98(83.7%) 0 0 19/82(23.2%)
Embryos derived from the transgenic line of Tg(cmlc2::GFP) were used, and the cardiac morphology was observed by fluorescence microscope. The major cardiac
phenotype of Nkx2.5/2.7-MO morphants revealed unlooping defects and shrunken ventricle; the major phenotype for Nkx2.7-MO morphants was looping defects with a
lesser rate of shrunken ventricle. The Nkx2.5-MO morphants displayed no obvious cardiac phenotype except pericardial edema. (‘‘—‘‘ represents no observation.) The
percentage of each abnormal phenotype was counted individually.
doi:10.1371/journal.pone.0004249.t001
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expression was not observed in the embryos (n=155) injected 6 ng
Nkx-specific MO together with 150 pg mRNA synthesized either
from pCS2-Nkx2.5-GFP or from pCS2-Nkx2.7-GFP (data not
shown). Embryos injected either with Nkx2.5-GFP and Nkx2.7-
MO, or with Nkx2.7-GFP and Nkx2.5-MO, distinctively express
GFP (data not shown). This evidence indicated that injection of
Nkx2.5-MO and Nkx2.7-MO can specifically block the translation
of the Nkx2.5 or Nkx2.7 mRNA, respectively. We also designed a 5-
bp mismatched binding sequence for Nkx2.7 MO, termed Nkx2.7-
MO-control, to serve as a control. Results showed that the
Nkx2.7-MO-control-injected zebrafish embryos exhibited the
wild-type-like phenotype when this control MO was injected at
a range of 6.0 to 16 ng. Thus, we conclude that the defective
phenotypes of morphants are induced specifically by the injection
of Nkx2.5/2.7-MO.
Nkx2.5 and Nkx2.7 function redundantly in zebrafish
heart development
To demonstrate the functions shared by Nkx2.5 and Nkx2.7,a s
well as the specificity of MO for Nkx2.5 and Nkx2.7, the Nkx2.5
mRNA or the Nkx2.7 mRNA was co-injected with MO into
zebrafish embryos. Results showed that co-injection of 9 ng
Nkx2.7-MO with 10 and 20 pg of Nkx2.5 mRNA in embryos
decreased the occurrence of heart defects from 55% to 32% and
22%, respectively (Table 2), indicating that the defective
phenotype of Nkx2.7 morphants was specifically rescued by
Nkx2.5 mRNA. Co-injection of 8 ng Nkx2.5-MO plus 8 ng
Nkx2.7-MO with 25 and 50 pg of Nkx2.5 mRNA in embryos
decreased the occurrence of heart defects from 91% to 73% and
58%, respectively (Table 2). Furthermore, co-injection of 8 ng
Nkx2.5-MO plus 8 ng Nkx2.7-MO with 0.25 and 0.5 pg of Nkx2.7
mRNA in embryos decreased the occurrence of heart defects from
92% to 61% and to 43%, respectively (Table 2), indicating that the
heart defects in embryos were rescued specifically by Nkx2.5- and
Nkx2.7- mRNA. Taken together, the decrease of heart defects
across samples indicates that Nkx2.7 and Nkx2.5 function
redundantly during the heart development of zebrafish embryos.
However, since rescue experiments were performed by substan-
tially decreasing the concentration of Nkx2.7 mRNA, we can
conclude that Nkx2.7 plays a functionally more predominant role
in heart formation.
Nkx2.5 was overexpressed in the Nkx2.7-MO-injected
embryos
In the wild-type embryos, Nkx2.5 was expressed predominantly
in the ventricle and weakly in the atrium at 48 hpf (Fig. 2A),
limiting ventricle expression when embryos developed at 72 hpf
(Fig. 2C). Unlike the Nkx2.5 expression in the wild-type, Nkx2.7-
knockdown morphants retained robust Nkx2.5 expression in
ventricle (Figs. 2B and 2D). Because Nkx2.7 was knocked down
and Nkx2.5 was overexpressed, these results also support the
hypothesis that Nkx2.5 and Nkx2.7 play similar roles in cardiac
morphogenesis in zebrafish and that, moreover, in the absence of
one, the other can compensate for the loss of function.
The ventricle became smaller and consisted of a single
layer in the Nkx2.5 and Nkx2.7 double knockdown
embryos
In addition to monitoring cardiac morphology by using heart-
tagged GFP zebrafish line Tg(cmlc2::GFP), we used vmhc as a
Table 2. Functional redundant activities between Nkx2.5 and
Nkx2.7 in zebrafish heart development.
Morpholino (ng) mRNA (pg) Total (n)
Heart
Defects (%)
Nkx2.5 Nkx2.7 Nkx2.5 Nkx2.7
0 9 ng 0 0 177 55%
0 9 ng 10 pg 0 109 32%
0 9 ng 20 pg 0 113 22%
8 ng 8 ng 0 0 146 91%
8 ng 8 ng 25 pg 0 278 73%
8 ng 8 ng 50 pg 0 169 58%
8 ng 8 ng 0 0 166 92%
8 ng 8 ng 0 0.25 pg 189 61%
8 ng 8 ng 0 0.5 pg 206 43%
For rescue study, the Nkx2.5 mRNA was co-injected with Nkx2.7-MO into
embryos derived from zebrafish transgenic line Tg(cmlc2::GFP). The percentages
of heart defects were decreased compared to phenotypes which occurred in
the embryos injected with Nkx2.7-MO alone. Similarly, either the Nkx2.5 or
Nkx2.7 mRNA enabled embryos to be rescued from the defects as a result of the
injection of Nkx2.5/2.7-MO. n: total number of embryos analyzed.
doi:10.1371/journal.pone.0004249.t002
Figure 1. The defective phenotypes of zebrafish embryo heart
injected with Nkx2.5-MO, Nkx2.7-MO and Nkx2.5/2.7-MO. Eight
nanograms of MO were injected into one-cell stage embryos derived
from transgenic line Tg (cmlc2::GFP) to knock down the Nkx protein
specifically. The embryos are shown at 36 hpf (A, B, C), 48 hpf (D, E, F),
and 72 hpf (G, H, I). The heart phenotype of Nkx2.5-MO embryos was
similar to that of control embryos whose ventricle is located at the right
side of the atrium when embryos were observed at 36 hpf, 48 hpf and
72 hpf from the ventral view under fluorescence microscope (A, D, G).
However, embryos injected with Nkx2.7-MO displayed an unlooping
defect from 36 hpf to 72 hpf (B, E, H). Embryos injected with Nkx2.5/2.7-
MO displayed a shrunken ventricle and an expanding atrium (C, F, I). v:
ventricle; a: atrium.
doi:10.1371/journal.pone.0004249.g001
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Compared to the wild-type, the ventricle of the Nkx2.5 and Nkx2.7
double knockdown embryos became smaller when they were
observed at 72 hpf. However, the expression level of vmhc in the
heart of the Nkx2.5/2.7- MO-injected embryos was similar to that
of wild type (Figs. 3A and 3B). It is worth noting that neither WT
nor Nkx2.5/2.7 morphant embryos expressed vmhc in the head
muscle until 72 hpf. Therefore, the Nkx2.5/2.7-MO morphants
did not appear less developed than WT embryos. This evidence
demonstrates that, although the ventricular fate is properly
determined in the Nkx2.5/2.7-MO-injected embryos, their
ventricular morphogenesis is abnormal.
In order to understand why the ventricle of Nkx2.5/2.7-MO-
injected embryos is smaller than that of wild-type embryos, we
performed a histological examination of the 72-hpf embryos.
Compared to the wild-type (Fig. 3C), a thinning layer of
myocardium with fewer cell numbers in the ventricle was observed
in the Nkx2.5/2.7 morphants (Fig. 3D). Additionally, the
endocardium was not observed to form an endocardial cushion
in these morphants (Fig. 3D). Finally, the TUNEL assay
demonstrated that the decrease of myocardium cell numbers in
the ventricle did not result from cell death, but rather from
defective proliferation of ventricular myocardium, which led to a
smaller heart with a thinning layer (Figs. 3E and 3F).
Heart deterioration occurring in the Nkx2.5/2.7
morphants results from defective myocardial
differentiation
The expressions of tbx5 and hand2 in the cardiac precursor
regions were normal in the Nkx2.5/2.7-MO-injected embryos at
12 hpf (Figs. 4A and 4C vs. 4B and 4D). These two markers were
present in the bilateral regions of the lateral plate mesoderm and
showed the correct anterioposterior localization with the same
expression level. Thus, the early cardiac marker genes were
transcribed normally in the Nkx2.5/2.7 morphants.
We also observed myocardial differentiation markers, such as
bmp4, versican, tbx5, and tbx20. BMP4 is one of the TGF-b
superfamily proteins and is involved in valve development during
the cardiac maturation stage. A ventricle-enriched expression of
bmp4 was the same between wild-type and Nkx-deficient embryos
from 31 to 33 hpf (data not shown). Moreover, in wild-type
embryos, bmp4 was found to express in the ventricle and inflow
tract at 48 hpf (Fig. 5A), and then it was expressed exclusively in
the atrioventricular junction at 72 hpf (Fig. 5D). However, unlike
the dynamic expression of bmp4 in the wild-type embryos, bmp4 in
the Nkx2.7 and in the Nkx2.5/2.7 morphants failed to change its
predominant ventricular and atrial expression pattern (Figs. 5B
and 5E; 5C and 5F). Similarly, versican was expressed broadly in
the atrium and weakly in the ventricle of the wild-type embryos at
33 hpf. This atrium-enriched expression of versican was the same
between wild-type and Nkx-deficient embryos (data not shown).
After 36 hpf, the versican expression of wild-type was restricted to
the AV boundary (Figs. 5G and 5J). However, Nkx2.7 and the
Nkx2.5/2.7 morphants still expressed a high level versican in the
atrium of the heart from 48 to 72 hpf (Figs. 5H and 5K; 5I and
5L). Nevertheless, we noticed that the versican was expressed in
otoliths of both the wild-type embryos and the Nkx-deficient
embryos by 72 hpf (Figs. 5J, 5K and 5L), indicating that the
Figure 2. Nkx2.5 was overexpressed in the Nkx2.7-knockdown
embryos. Nine nanograms of Nkx2.7-MO were injected into one-cell
stage of embryos. Nkx2.5 was expressed predominantly in ventricle (v)
and weakly in atrium (a) of wild-type (WT) embryos at 48 hpf (A), but
only minimally and weakly in ventricle at 72 hpf (C). However, the
Nkx2.7-MO-injected embryos retained robust Nkx2.5 expression in
ventricle both at 48 and 72 hpf (B and D). The embryonic stages were as
indicated, and embryos were observed ventrally. v: ventricle; a: atrium.
doi:10.1371/journal.pone.0004249.g002
Figure 3. Ventricle becomes smaller and consists of a single
layer in the Nkx2.5 and Nkx2.7 double knockdown morphants
(Nkx2.5/2.7-MO). Ventricular myosin heavy chain (vmhc) was used as
a probe to detect the ventricle morphology in (A) wild-type (WT) and (B)
Nkx2.5/2.7-MO embryos at 72 hpf. The ventricle of Nkx2.5/2.7-MO
embryos was smaller than that of WT embryos (indicated by arrows).
Hematoxylin and eosin staining showed that ventricular myocardium of
WT was two or more cell layers in thickness. However, only one cell
layer was retained in the ventricular myocardium of the Nkx2.5/2.7-MO
embryos. In addition, compared to wild-type embryos, the endocardi-
um of Nkx2.5/2.7-MO-injected embryos did not form endocardial
cushion (indicated by arrowheads in C and D). Like WT embryos, TUNEL
assay did not display the increase of TUNEL-positive cells in the heart
region of Nkx2.5/2.7-MO embryos at 40 hpf (indicated by boxes in E and
F). Embryos were observed ventrally (A–B) or laterally (C–F). v: ventricle;
a: atrium.
doi:10.1371/journal.pone.0004249.g003
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the defects caused by Nkx-MO were specific in the heart, not in
otoliths (Figs. 5J, 5K and 5L).
In the wild-type embryos, tbx5 expression was slightly greater in
the atrium than the ventricle at 26 hpf, which was consistent with
what Garrity (2002) reported [25]. Then, the gradient expression
of tbx5 was changed from atrium-rich expression to ventricle-rich
expression at 48 hpf (Figs. 6A and 6D). However, in the Nkx2.7
and Nkx2.5/2.7 morphants, the tbx5 expression remained atrium-
rich at 48 hpf (Figs. 6B and 6C), and even beyond 48 hpf (Figs. 6E
and 6F). In an overview of the whole heart, the expression level of
tbx5 was greater in morphants than the wild-type embryos.
Although the dynamic change of tbx5 expression pattern from
atrium to ventricle in the wild-type at later stages did not occur in
the Nkx2.7 or the Nkx2.5/2.7 morphants, the expression level of
tbx5 in pectoral fin bud of morphants was the same as wild-type
embryos.
We also detected another myocardial differentiation marker,
tbx20, which was expressed during cardiac development. In the
wild-type, this marker was expressed more predominantly in the
ventricle than in the atrium at 48 hpf (Fig. 6G). The expression of
tbx20 was confined to the outflow tract, AV canal and inflow tract
at 72 hpf (Fig. 6J); however, its expression in the Nkx2.7 and the
Nkx2.5/2.7 morphants maintained a strong signal in the ventricle
and atrium of the heart (Figs. 6H and 6K; 6I and 6L). While this
behavior was unlike the tbx20 expression patterns in the wild-type
embryos, the expression level of tbx20 in the outflow tract of
morphants was, nevertheless, the same as wild-type embryos. Still,
we noticed that, like wild-type embryos, the expression level of
tbx20 in tegmentum of the Nkx2.7 and Nkx2.5/2.7 morphants
started to gradually decrease from 48 to 72 hpf (Figs. 6J, 6K and
6L), indicating that, although all these morphants developed to
later stages without delay, they also exhibited specific heart defects.
In summary, we examined the expression patterns of myocar-
dial differentiation markers, including bmp4, versican, tbx5 and
tbx20, in the Nkx2.7-MO- and Nkx2.5-/2.7-MO-injected embry-
os. While the expression levels of these markers were the same as
those at the early stage of the wild-type, we found that they
became more intensive than those of the wild-type at the later
stage, suggesting that myocardial differentiation is defective in the
morphants. We also noticed that the hearts of these Nkx2.7- and
Nkx2.5/2.7-MO-injected embryos finally deteriorated and be-
came string-like in form without undergoing further development.
Taken together, this line of evidence suggests that the late onset of
myocardial differentiation results in heart defects at a later
maturation stage of cardiogenesis in the Nkx-knockdown embryos.
Overexpression of Nkx2.7 or Nkx2.5 causes cardiac
defects similar to those induced by Nkx-knockdown
To examine whether Nkx2.7 plays roles similar to those of
Nkx2.5 in cardiogenesis, we studied the effect of Nkx overexpres-
sion on heart development by injection of either Nkx2.7 or Nkx2.5
mRNA into one-celled stage embryos derived from transgenic line
Tg(cmlc2::GFP), which has heart-specific GFP. By fluorescence
microscopy, we observed that overexpression of 5 pg Nkx2.7
Figure 4. Early cardiac markers express normally in the Nkx2.5
and Nkx2.7 double knockdown morphants (Nkx2.5/2.7-MO).
Whole mount in situ hybridization showed that the expression patterns
of hand2 and tbx5, lateral plate mesoderm markers, were similar
between wild-type (WT) and Nkx2.5/2.7-MO embryos at 10 hpf (A vs. B;
C vs. D, respectively). Arrows: heart field.
doi:10.1371/journal.pone.0004249.g004
Figure 5. Abnormal cardiac differentiation occurred in the
Nkx2.7-knockdown zebrafish embryos. The expressions of bmp4
(A–F) and versican (G–L) in hearts were compared between wild-type
(WT) (A, D, G, J), Nkx2.7-MO- (B, E, H, K) and Nkx2.5/2.7-MO- injected
embryos (C, F, I, L) at 48 (A–C, G–I) and 72 hpf (D–F, J–L). In WT embryos,
bmp4 was expressed in the ventricle and inflow tract at 48 hpf (A), and
then bmp4 was restricted in its expression at the AV boundary at 72 hpf
(D). However, in the Nkx2.7-MO (B, E) and Nkx2.5/2.7-MO (C, F) embryos,
bmp4 was still expressed predominantly in the ventricle and atrium
from 48 to 72 hpf. Similarly, in WT embryos, the versican expression was
more predominant in ventricle than in atrium, at about 31 to 33 hpf,
and then versican was confined in its expression at the AV boundary
after 33 hpf (G, J). In contrast, in the Nkx2.7-MO (H, K) and Nkx2.5/2.7-
MO (I, L) embryos, the versican was significantly expressed in the atrium
and ventricle. In addition, the versican expression pattern in otoliths
remained unchanged (J, K, and L). All images are ventral views, anterior
to the top. a: atrium; v: ventricle; i: inflow tract; av: atrioventricular
boundary; ot: otoliths.
doi:10.1371/journal.pone.0004249.g005
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150 pg Nkx2.5 mRNA. These defects included a small patch of
cardiac cells (64% in the 150-pg-Nkx2.5-overexpressed embryos;
28% in the 5-pg-Nkx2.7-overexpressed embryos), malposition of
cardiac migration (13% in the 150-pg-Nkx2.5-overexpressed
embryos; 2% in the 5-pg- Nkx2.7-overexpressed embryos), and
an enlarged heart (18% in the 5-pg- Nkx2.7-overexpressed
embryos) (Figs. 7A–F). Moreover, injection of Nkx2.5 mRNA in
the amount of 150 pg also caused 41% of embryos (62/150) to
have a dorsoventral axial defect, whereas injection of Nkx2.5
mRNA in the amount of 50 pg caused 22% of embryos (30 out of
135) to have an enlarged heart (data not shown). Based on this
evidence, we suggest that Nkx2.7 carries out functions similar to
those of Nkx2.5, but that Nkx2.7 appears to play a more prominent
role in zebrafish heart development. This conclusion is based on
the contrasting concentrations of mRNA required to generate
similar heart defects; i.e., 5 pg Nkx2.7 mRNA vs. 150 pg Nkx2.5
mRNA.
The expressions of tbx5 and tbx20 are modulated by
Nkx2.7
In addition to the cardiac defects occurring in the embryos that
were overexpressed in either Nkx2.5 or Nkx2.7, we noticed that
embryos injected with 150 pg of either Nkx2.5 or Nkx2.7 mRNA
suffered a severe defect in ventralization (data not shown).
However, this ventralization defect was not observed in the
embryos that were treated with either Nkx2.7- or/and Nkx2.5-
knockdown. This inconsistency between loss- and gain-of-function
of Nkx2.5 or Nkx2.7 may result from the possibility that either
Nkx2.7 or Nkx2.5 plays additional roles in zebrafish heart
development before the late-gastrula period. Therefore, in order
to further confirm the specific effects caused by the overexpression
of Nkx2.7 in the heart after gastrulation, we constructed a
dexamethasone-inducible plasmid in which the ligand-binding
domain of GR was fused with the coding region of Nkx2.7. When
we added dexamethasone to the 10-hpf embryos derived from the
transgenic line Tg(cmlc2::GFP), these embryos were fixed at 48-
hpf. Results showed that the cardiac maturation was defective,
including an unlooping or shrunken heart (Fig. 8B), although the
dorsoventral axis formation was not affected in the GR-Nkx2.7-
produced embryos (Figs. 8D and 8F). We also noticed that, unlike
wild-type embryos, the expressions of tbx5 and tbx20 in these GR-
Nkx2.7-produced embryos were reduced at 48 hpf (Figs. 8D and
8F). Moreover, compared to the unchanged expression levels of
tbx5 in eyes (Fig. 8C vs. 8D) and tbx20 in brain (Fig. 8E vs. 8F), the
effect of Nkx2.7 overexpression on the reduced expressions of tbx5
and tbx20 was heart specific. This evidence strongly suggests that
Nkx2.7 modulates the expression of tbx5 and tbx20, which, in turn,
affects cardiac differentiation.
Discussion
Using two Nkx2.5- and Nkx2.7-specific MOs, we demonstrated
that Nkx2.5 and Nkx2.7 are required for normal heart develop-
ment. Prior to the onset of cardiac looping, cardiogenesis
progresses normally in both Nkx2.7-MO and Nkx2.5/2.7-MO,
indicating that Nkx is not an essential requirement for the early
stage of heart development. However, at 36 hpf, when heart
development reaches the looping stage, Nkx2.7 morphants showed
an unlooping defect. Moreover, Nkx2.5/2.7 morphants not only
displayed an unlooping defect, but also a shrunken ventricle. In
addition, the expression of differentiated marker genes, including
bmp4, versican, tbx5 and tbx20, was abnormal either in the ventricle
or in both the ventricle and atrium (Figs. 5 and 6). Although the
formation of two distinct chambers was enabled in Nkx2.7 and
Nkx2.5/2.7 morphants, the hearts were not processed further,
remaining, instead, a linear tube, resulting in abnormal contrac-
tions and arrhythmia.
Nkx2.7, a member of the tinman family of related genes, contains
the tinman-like amino terminal decapeptide, homeobox, and NK2
domain. Nkx2.7 exhibits temporal and spatial expression patterns
very similar to Nkx2.5 during zebrafish cardiac development,
although the onset of Nkx2.7 at the 10.5 hpf comes somewhat
earlier than that of Nkx2.5. In addition, Nkx2.7 is also detected with
a co-localized expression pattern at pharyngeal endoderm
progenitors like Nkx2.3 [19]. These expression profiles indicate
that Nkx2.7 and Nkx2.5 are closely associated in the roles they play
in the context of the regulation of cardiac differentiation.
In Drosophila, tinman is essential for primary cell lineage
determination and early morphogenesis. Embryos that lack tinman
function do not develop any dorsal vessel or gut muscle progenitor
cells [6]. Nkx2.5, the mouse homolog of tinman, is an early marker
of cardiomyocyte precursors. In the knockout of Nkx2.5 by gene
Figure 6. Chamber maturation was affected in the Nkx2.7-
knockdown zebrafish embryos. The expressions of tbx5 (A–F) and
tbx20 (G–L) in hearts were compared between wild-type (WT) (A, D, G,
J), Nkx2.7-MO- (B, E, H, K) and Nkx2.5/2.7-MO- injected embryos (C, F, I,
L) at 48 (A–C, G–I) and 72 hpf (D–F, J–L). In WT embryos, tbx5 was
expressed strongly in ventricle, but weakly in atrium at 48 hpf and
beyond (A, D). However, in the Nkx2.7-MO (B, E) and Nkx2.5/2.7-MO (C,
F) embryos, tbx5 retained its strong expression in the heart, although
the expression pattern was gradually changed from ventricle-enriched
expression to atrium-enriched expression from 48 hpf to 72 hpf (B and
E; C and F). In WT embryos, tbx20 expression was similar to the
expression gradient of tbx5 in the heart at 48 hpf, and the tbx20
expression was stronger than that of tbx5. In addition, tbx20 expression
was also detected in outflow tract at 48 hpf (G), and tbx20 expression
was restricted to outflow tract and inflow tract by 72 hpf (J). However,
in Nkx2.7-MO (H, K) and Nkx2.5/2.7-MO (I, L) embryos, tbx20 was
expressed strongly in the heart and outflow tract from 48 to 72 hpf. All
images are ventral views, anterior to the top. v: ventricle; a: atrium. ot:
outflow tract; i: inflow tract.
doi:10.1371/journal.pone.0004249.g006
Nkx in Cardiac Morphogenesis
PLoS ONE | www.plosone.org 6 January 2009 | Volume 4 | Issue 1 | e4249targeting techniques, mouse embryos are arrested at the looping
stage [7]. Surprisingly, this mouse Nkx2.5-knockout embryo does
not exhibit the same defective phenotype of tinman null embryos,
indicating that there are other Nkx2.5 homologs to compensate for
Nkx2.5 loss of function in mouse heart development. For example,
Nkx2.6 compensates for Nkx2.5 functions in the pharyngeal
endoderm of mouse embryos, but not in hearts [14]. Recently,
mouse Nkx2.7 was found (GeneID: 108060). Thus, it is
worthwhile to study whether mouse Nkx2.7 functions redundantly
with mouse Nkx2.5 in a way that is similar to zebrafish Nkx2.7 and
Nkx2.5.I nXenopus, Cleaver et al. (1996) [9] suggested that XNkx2.3
and XNkx2.5 play the same roles in cardiac development. In
zebrafish, we demonstrate in this study that Nkx2.7 does
compensate for the loss of Nkx2.5 function in cardiac morpho-
genesis.
Recently, Targoff et al. (2008) [26] demonstrated that Nkx2.5/
Nkx2.7 morphants of zebrafish are well developed at early
embryonic stage; however, morphants fail to elongate normally
at heart tube stage. Thus, the authors concluded that abnormal
heart tube extension will cause cardiac differentiation effects on
ventricular and atrial cell numbers. In this study, we also observed
similar phenotypes of Nkx2.5/Nkx2.7 morphants in that the heart
tubes of Nkx2.5/Nkx2.7 morphants cannot extend further and the
ventricle portion displays shorter and wider than that of wild-type
embryo. However, in our study, we described the defective
phenotypes and studied the functions of Nkx2.5/Nkx2.7 in more
detail. To summarize, we first observed the cardiac phenotype at
various developmental stages, including the period from 26 to 55
hpf when zebrafish ventricle is undergoing differentiation and
proliferation. Targoff et al. (2008) [26], on the other hand, did not
investigate this important period of time. Second, by taking the
advantage of zebrafish transgenic line Tg(cmlc2::GFP), which
possesses the heart-specific GFP signal, we were able to observe
the dynamic change of ventricular morphology in live embryos. In
so doing, we found that the ventricle of Nkx2.5/Nkx2.7
morphants retained the pre-mature phase during this period
rather than undergoing further cardiac morphogenesis. Thus, we
suggested that the differentiation and proliferation of ventricle in
Nkx2.5/Nkx2.7 morphants may cease after 26 hpf, resulting in the
decrease of cell numbers of ventricle at the later stages. Third, by
detecting the differentiated markers, such as versican, bmp4, tbx5
and tbx20, we also found that the expression patterns of these
markers in Nkx-deficient embryos were the same as those of wild
type at early heart tube stage. However, the expressions of these
markers in Nkx-deficient embryos were not restrained to the places
where they should be confined at later cardiac differentiation
stage. Based on these lines of evidence, we suggest that the
decrease of ventricular myocardial proliferation and the defective
myocardial differentiation both result from the up-regulation of
bmp4, versican, tbx5 and tbx20 at late stage, even though these genes
are all expressed normally in hearts at an early heart tube stage.
Fourth, we performed a histological examination of the 72-hpf
embryos and found that, compared to the wild-type, a thinning
layer of myocardium with fewer cell numbers in the ventricle was
observed in the Nkx2.5/2.7 morphants and that the endocardium
of morphants did not form an endocardial cushion (Figs. 3C and
3D). Fifth, by using histological section of the Nkx2.5/2.7-MO-
injected embryos, we found that the formation of atrioventricular
valves was abnormal at 72 hpf (Fig. 3D).
We observed that the heart of Nkx2.5/2.7-MO double-
knockdown morphants appeared to have a vigorous and rhythmic
peristaltic contraction initially. Subsequently, however, the hearts
of these double knockdown morphants failed to undergo looping
morphogenesis, and the contractile function diminished progres-
sively. Moreover, blood was regurgitated within the heart chamber
after 72 hpf, and the heart became silent with cessation of blood
circulation by 84 hpf. These defective phenotypes could have
resulted from valve dysfunction. Interestingly, both bmp4 and
Figure 7. Overexpression of Nkx2.5 and Nkx2.7 in embryos resulted in serious heart defects. Amounts equaling 150 pg Nkx2.5 mRNA (A–
C) and 5 pg Nkx2.7 mRNA (D–F) were injected individually into one-celled stage embryos derived from transgenic line Tg(cmlc2::GFP), whose hearts
were specifically tagged with green fluorescent protein. We observed that there were many phenotypes of heart defects at 48 hpf resulting from the
overexpression of either Nkx2.5 mRNA or Nkx2.7 mRNA. These defects included malposition of the reducing heart (A, D), bilateral heart (B, E), small
heart (C) and large heart (F). Interestingly, overexpression by injection of Nkx2.7 mRNA as low as 5 pg caused an effect similar to that induced by
injection 30 greater times than that of Nkx2.5 mRNA. (A, C, D, F), lateral views; (B, E), dorsal views; Arrows: green fluorescent heart.
doi:10.1371/journal.pone.0004249.g007
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later stage of heart development [27]. Both genes are involved in
cardiac valve formation and both are examined in this study.
Moreover, it has been found that mutation of Apc [28] or NXT2
[29] of zebrafish showed that expression of bmp4 and versican genes
are upregulated and that domains are expanded throughout the
hearts. Similarly, in this study, we found that bmp4 and versican are
dramatically upregulated and that the domains of expression are
greatly expanded to the ventricle in the hearts of Nkx2.5/2.7
morphants. Therefore, we speculate that blood regurgitation
occurring in the Nkx2.5/2.7 morphants’ hearts resulted from valve
dysfunction, which, in turn, causes the defective morphogenesis
and function of heart.
Prall et al. (2007) [30] used cDNA microarray analysis to
compare the transcripts of mouse Nkx2.5 heterozygous and null
mutant embryos from E8.0 to E9.5 and found that tbx5 is
upregulated two-fold greater in null embryos at E8.0-E8.5. We
found that both Nkx2.7 and Nkx2.5/2.7 morphants exhibit
overexpression of tbx5 and tbx20 in heart, suggesting that Nkx2.5
and Nkx2.7 may be negative modulators of tbx5 and tbx20 in
zebrafish. Therefore, the finding of Prall et al. supports our present
study. On the other hand, Prall et al. (2007) [30] also demonstrated
that there is an Nkx2.5/Bmp2/Smad1 negative loop pathway to
regulate heart precursor specification and proliferation. They
pointed out that Nkx2.5 null mutants cause over-specification of
cardiac progenitors and that the area of over-specification of
cardiac progenitors appears to be a broad expression of early
cardiac markers in the cardiac crescents. Most importantly, Prall et
al. (2007) [30] further stated that impaired proliferation of
secondary heart field-derived cells, which contribute to most
ventricle cells, results from over-specification of cardiac progen-
itors. For this reason, Nkx2.5 null mutants have a thin ventricular
myocardium.
However, in our study, the expression of early cardiac markers,
tbx5 and hand2, do not exhibit expansion of cardiac progenitors
(Figs. 4A–4D), indicating that the over-specification of cardiac
progenitors does not occur. Instead, the Nkx2.5/2.7-MO-injected
embryos consist of a single layer of ventricle, which does not result
from over-specification of progenitors in a manner similar to
mouse Nkx2.5 null mutants. At the same time, tbx5 was
overexpressed in the ventricle and atrium of zebrafish (Fig. 6F).
The fact that overexpression of tbx5 in the heart inhibits
cardiomyocyte proliferation has been demonstrated in mice [31]
and chicks [32], suggesting that the function of tbx5 acts as growth
arrest signal to regulate cellular proliferation. Thus, it is reasonable
to conclude that the thin-layer of heart of zebrafish Nkx2.5/2.7
morphants may result from the effect of higher expression of tbx5.
Therefore, we reason that the heart defect induced by the
knockdown of Nkx2.5/2.7 is more likely to be caused by the late
onset of cardiac differentiation. It was also demonstrated in this
study that Nkx2.7 is a modulator of tbx5 and tbx20 expression,
which further supports the conclusion noted above and gives
added support to the prominent role Nkx2.7 plays in cardiac
morphogenesis.
Chen and Fishman (1996) [10] reported that overexpression of
Nkx2.5 (100 pg) in zebrafish causes a large hyperplastic heart with
normal function and chamber morphology. Moreover, injection of
a higher dose (250 pg) of Nkx2.5 mRNA affected the dorsoventral
axis of embryos severely. Cleaver et al. (1996) [9] also
demonstrated that overexpression of Nkx2.5 and Nkx2.3 in Xenopus
resulted in a hyperplastic heart. In our study, injection of 150 pg of
Nkx2.5 mRNA or 5 pg of Nkx2.7 mRNA obtained results similar to
Chen and Fishman (1996) [10]. Injection of 50 pg of Nkx2.5
mRNA caused 22% of embryos (30 out of 135; 30/135) to have an
enlarged heart and injection of 150 pg of Nkx2.5 mRNA caused
64% of embryos (67/104) to have a reduced heart, whereas
injection of 5 pg of Nkx2.7 mRNA caused 18% (32/182) and 28%
(51/182) of embryos to have a reduced heart and an enlarged
heart, respectively. Our data are supported by the paper published
by Chen et al. (1996) [10], who demonstrated that embryos
injected with 100 pg Nkx2.5 mRNA showed an enlarged heart, but
embryos injected with 250 pg Nkx2.5 mRNA displayed bilateral
beating heart, reduced heart or dorsal-ventral axial defects. We
speculate that ectopic expression of Nkx2.5 mRNA at the one-cell
stage results in nonspecific defects in zebrafish embryos. For
example, there are no reports about Nkx2.5 function in dorsal-
ventral axis formation. Based on this point, we suggest that Nkx2.7
carries out functions similar to those of Nkx2.5, but, because there
may be many unexpected effects on embryos from overexpression
of either Nkx2.5 or Nkx2.7, we performed a specific knockdown of
morpholino and a GR-inducible assay to learn the exact functions
of Nkx2.5 and Nkx2.7 in zebrafish development. Specifically, we
note that injection of 5 pg Nkx2.7 mRNA results in a phenotype
similar in defect to the injection of 150 pg Nkx2.5 mRNA (Fig. 7).
Compared to the injection dosage of Nkx2.5 mRNA, we notice
that only a one-thirtieth concentration of Nkx2.7 mRNA is
required to rescue the defects induced by Nkx2.5 and 2.7 double
Figure 8. The expressions of tbx5 and tbx20 were modulated by
Nkx2.7. Each embryo derived from transgenic line Tg(cmlc2::GFP),
whose heart was specifically tagged with green fluorescent protein, was
injected with 0.15 ng of plasmid, in which Nkx2.7 mRNA was
transcribed conditionally by adding dexamethasone. All embryos were
treated with dexamethasone at 10 hpf and took a ventral view at 48 hpf
to observe the cardiac development under the fluorescence micro-
scope. The cardiac morphologies of the control embryos and the GR-
Nkx2.7-overexpression embryos were shown. Compared to the control
(A), various cardiac defects were found in around 35% of embryos from
the GR-Nkx2.7-overexpression group, including unlooping and shrunk-
en heart (B). In addition, the expressions of tbx5 (C, D) and tbx20 (E, F)
were down-regulated in the GR-Nkx2.7-overexpresion embryos. How-
ever, the expression levels of tbx5 in eyes (indicated by arrows in C and
D) and tbx20 in brain (indicated by arrows in E and F) remained
unchanged. v: ventricle; a: atrium.
doi:10.1371/journal.pone.0004249.g008
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function than Nkx2.5.
Finally, in the loss-of-function experiment, the ventralized
embryos were not observed in the Nkx2.5/2.7-knockdown
embryos. In contrast, these results were observed in the gain-of-
function experiment, in which Nkx2.5 and Nkx2.7 were overex-
pressed. However, based on the GR-Nkx2.7 inducible experiment
where Nkx2.7 is induced after gastrulation, we proved that Nkx2.7
has a specific effect on heart development, but not axis formation
(Fig. 8). Therefore, we speculate that this inconsistency between
gain-of-function and loss-of-function experiments may result from
the fact that Nkx2.5 and Nkx2.7 are not expressed until late-
gastrula stage. However, since either the overexpressed Nkx2.5 or
Nkx2.7 is injected at the one-cell stage, these misexpressional genes
can cause abnormal axis formation in embryogenesis. In
conclusion, we find that Nkx2.7 and Nkx2.5 act as functional
homologs of tinman in the zebrafish embryos. While Nkx2.5 and
Nkx2.7 play redundant roles in cardiac morphogenesis, Nkx2.7
appears to have a more critical function in its effect on cardiac
differentiation, as indicated by the gain-of-function and loss-of-
function experiments where Nkx2.7 is observed to regulate the
expressions of tbx5 and tbx20 through the heart tube stage.
Materials and Methods
Fish husbandry and observation
The wild-type AB strain [33] and the transgenic line Tg
(cmlc2::GFP) [34] of zebrafish were cultured at 28.5uC. Embryos
were staged by hours post fertilization (hpf) [35]. The phenotype of
heart formation was observed under a fluorescent stereomicro-
scope, MZ FLIII (Leica). Images were captured with a Fine pix S2
pro camera (Nikon) using the Camera Shooting software.
Morpholino (MO) knockdown
The MOs designed specifically for blocking the translation of
Nkx2.5 and Nkx2.7 mRNAs were TCATTTGGCTAGAGAA-
CATTGCCAT (Nkx2.5-MO) and GTCACAGGACTCGGAAG-
CATCGTGC (Nkx2.7-MO), respectively. A control MO specific
for Nkx2.7 was designed as GTgACAcGACTCcGAAG-
gATCGTcC (Nkx2.7-MO-control), in which a 5-bp mismatched
sequence of Nkx2.7 is indicated in lower case. All MOs were
prepared at a stock concentration of 1 mM and diluted to the
desired concentration for microinjection into each embryo.
Plasmid construct
In order to further demonstrate the specificity of MO targeting,
we constructed plasmids of pCS2-Nkx2.5-GFP and pCS2-Nkx2.7-
GFP, in which the binding sequence of either Nkx2.5-MO or
Nkx2.7-MO was fused with the GFP reporter cDNA. The NotI-cut
pCS2-Nkx2.5-GFP, pCS2-Nkx2.7-GFP or pCS2-GFP served as a
template to synthesize RNA using the mMessage Machine kit
(Ambion). The synthesized RNA (100 pg per embryo) was co-
injected with Nkx-specific MO or alone into one-celled zebrafish
embryos. The appearance of GFP in the treated embryos was
observed at the 24-hpf stage using green fluorescent microscopy.
In order to avoid nonspecific effect of the overexpressed Nkx2.7
in the early gastrula stage, we constructed a dexamethasone-
inducible plasmid, pCS2GR-Nkx2.7, in which the human
glucocorticoid receptor (GR) ligand binding domain was fused
with Nkx2.7.
Whole-mount in situ hybridization and TUNEL assay
Whole-mount in situ hybridization was performed as previously
described [36]. Antisense probes used in this study were as follows:
versican [27]; bmp4 [37]; tbx5 [25]; tbx20 [38] and vmhc [39]. The
TUNEL assay was performed as described previously [40] using
The DeadEnd
TM Colorimetric TUNEL System (Promega).
Rescue and overexpression experiments
Capped mRNA transcripts of Nkx2.5 and Nkx2.7 for either
rescue or overexpression experiments were synthesized by SP6 in
vitro transcription according to the protocol of the manufacturer
(Epicentre). We synthesized the truncated Nkx2.5 and Nkx2.7
mRNAs that did not include the specific MO-target site to avoid
affecting rescue efficiency. The resultant mRNAs were diluted to
the desired concentration (from 150 to 250 pg/ml), and approx-
imately 2.3 nl was microinjected into one-celled stage embryos.
For the GR-induced experiment, capped mRNA of a NotI-cut CS2
template contained an insert of the human GR ligand binding
domain fused with Nkx2.7. The resultant mRNAs were diluted to
2.3 nl of RNA at a concentration of 0.15 ng and were injected into
one-celled embryos. When the injected embryos developed at
gastrula stage (10-hpf), we immersed embryos with 10 um
dexamethasone in phenylthiourea water to induce the synthesis
of GR-Nkx2.7.
Histology
For paraffin section, embryos were collected at 72 hpf and fixed
in 4% PFA for 16 h. Then they were decalcified, dehydrated in a
graded series of ethanol, and embedded in paraffin for sectioning
into a 5-mm thickness [41]. The resultant sections were rinsed in
distilled water, washed with 0.01 M phosphate buffered saline,
and stained with hematoxylin and eosin.
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